[{"resourceType":"ValueSet","id":"2.16.840.1.113883.3.117.1.7.1.211","meta":{"versionId":"34","lastUpdated":"2021-03-17T15:57:59.000-04:00","profile":["http://hl7.org/fhir/StructureDefinition/shareablevalueset","http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"]},"extension":[{"url":"http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate","valueDate":"2021-03-17"}],"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.211","identifier":[{"system":"urn:ietf:rfc:3986","value":"urn:oid:2.16.840.1.113883.3.117.1.7.1.211"}],"version":"20210220","name":"Injectable Factor Xa Inhibitor for VTE Prophylaxis","title":"Injectable Factor Xa Inhibitor for VTE Prophylaxis","status":"active","experimental":false,"date":"2021-02-20T01:02:00-05:00","publisher":"TJC EH Steward","expansion":{"identifier":"urn:uuid:57e06806-fb99-4814-b8c7-f481ca7acae8","timestamp":"2023-12-20T21:33:22-05:00","total":4,"offset":0,"parameter":[{"name":"count","valueInteger":1000},{"name":"offset","valueInteger":0}],"contains":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"12042023","code":"861356","display":"0.8 ML fondaparinux sodium 12.5 MG/ML Prefilled Syringe"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"12042023","code":"861360","display":"0.5 ML fondaparinux sodium 5 MG/ML Prefilled Syringe"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"12042023","code":"861363","display":"0.4 ML fondaparinux sodium 12.5 MG/ML Prefilled Syringe"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"12042023","code":"861365","display":"0.6 ML fondaparinux sodium 12.5 MG/ML Prefilled Syringe"}]}}]
